Alía P, Villabona C, Giménez O, Sospedra E, Soler J, Navarro M A
Department of Clinical Chemistry, Hormone and Genetics Unit, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain.
Clin Endocrinol (Oxf). 2006 Sep;65(3):346-51. doi: 10.1111/j.1365-2265.2006.02602.x.
No consensus exists until now about the suitable dose of tetracosactin in the ACTH stimulation test for detecting adrenal insufficiency. Our aim was to characterize both the ACTH(1-24) and the cortisol profiles after standard high-dose test (250 microg) (HDT) and low-dose test (1 microg) (LDT) in healthy subjects in order to provide a deeper knowledge about the relationship between stimulus and response.
ACTH tests were performed in 10 healthy volunteers (five men, five women) with at least 1 week of difference.
Plasma ACTH(1-24) and ACTH(1-39) and serum cortisol were measured before tetracosactin i.v. injection and at 5, 15, 30, 45, 60, 75 and 90 min after stimulus. Area under the curve (AUC) of ACTH(1-24) and cortisol, as well as mean residence time (MRT) for ACTH(1-24) were calculated in both tests.
Elimination of ACTH(1-24) was faster in HDT than in LDT (MRTs of 0.14 vs 0.37, respectively, P = 0.008), but plasma concentrations were higher up to 60 min cortisol production in HDT reaching a higher maximum concentration (Cmax: 1144 vs 960 nmol/l) but delayed in time (75 vs 52.5 min). No significant relationship was observed between AUC or Cmax of ACTH(1-24) and AUC, Cmax and increment of cortisol in any of the tests. However, a negative correlation of basal cortisol values was observed with relative cortisol increment (HDT: r = 0.77 P = 0.009; LDT: r = 0.94 P < 0.0001), but not so with Cmax (HDT: r = 0.22 P = 0.55; LDT: r = 0.57 P = 0.09).
The elimination rate of ACTH in healthy volunteers was significantly lower in LDT than in HDT, but cortisol production rate appears to be identical in both tests, so that a maximum adrenal stimulation seems to exist. The use of LDT may be more adequate, although data from patients need studying.
迄今为止,在用于检测肾上腺功能不全的促肾上腺皮质激素(ACTH)刺激试验中,关于替可克肽的合适剂量尚无共识。我们的目的是对健康受试者在标准高剂量试验(250微克)(HDT)和低剂量试验(1微克)(LDT)后的促肾上腺皮质激素(1-24)和皮质醇谱进行特征分析,以便更深入了解刺激与反应之间的关系。
对10名健康志愿者(5名男性,5名女性)进行ACTH试验,每次试验间隔至少1周。
在静脉注射替可克肽前以及刺激后5、15、30、45、60、75和90分钟测量血浆促肾上腺皮质激素(1-24)、促肾上腺皮质激素(1-39)和血清皮质醇。计算两次试验中促肾上腺皮质激素(1-24)和皮质醇的曲线下面积(AUC)以及促肾上腺皮质激素(1-24)的平均驻留时间(MRT)。
HDT中促肾上腺皮质激素(1-24)的消除速度比LDT快(MRT分别为0.14和0.37,P = 0.008),但在60分钟内血浆浓度更高,HDT中皮质醇产生达到更高的最大浓度(Cmax:1144对960纳摩尔/升)但时间延迟(75对52.5分钟)。在任何一次试验中,促肾上腺皮质激素(1-24)的AUC或Cmax与皮质醇的AUC、Cmax和增量之间均未观察到显著关系。然而,观察到基础皮质醇值与相对皮质醇增量呈负相关(HDT:r = 0.77,P = 0.009;LDT:r = 0.94,P < 0.0001),但与Cmax无此关系(HDT:r = 0.22,P = 0.55;LDT:r = 0.57,P = 0.09)。
健康志愿者中LDT的促肾上腺皮质激素消除率明显低于HDT,但两次试验中皮质醇产生率似乎相同,因此似乎存在最大肾上腺刺激。尽管需要研究患者数据,但使用LDT可能更合适。